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Introduction {#sec1}
============

Myocardial infarction (MI) is defined by extensive myocardial cell death due to prolonged ischemia ([@bib80]) and remains a main cause of morbidity and mortality worldwide. The ability to regenerate the heart in lower vertebrates and neonates has been attributed to the proliferation of pre-existing cardiomyocytes ([@bib21]), a property that is almost entirely lost in the adult mammalian heart, where response to injury results in the formation of a scar. The outcome of the repair process is highly dependent on the extent of myocardial death and on the interplay between the inflammatory response and fibrosis ([@bib22]), which can lead to rupture or adverse ventricular remodeling and heart failure.

Cardiac interstitial cells are increasingly recognized as main players in organ injury response. They constitute 60%--70% of the total cells of the heart and include immune cells, endothelial cells, smooth muscle cells (SMCs), pericytes, fibroblasts, and various putative stem cell populations. Traditionally, most mesenchymal cell types in the heart have been defined and sub-selected based on the expression of surface markers, but no stem cell marker identified to date is unique to a particular stromal cell type, and the relations of putative stem cell sub-populations to other mesenchymal cells in the cardiac interstitium are unclear ([@bib22]). While the existence of any significant population of resident cardiac stem cells in the adult heart has been largely disproved ([@bib10]), heterogeneity in the mesenchymal-stromal fraction of the mammalian cardiac cellulome likely indicates a spectrum of different functions in both homeostasis and response to injury ([@bib70]).

Previous explorations of cardiac cellular diversity in the mouse heart characterizing single-cell transcriptional profiles of major non-myocyte cell populations ([@bib18], [@bib44], [@bib62], [@bib70]) have yielded valuable insights into the structure of the cardiac cellulome. To develop a more definitive compendium of interstitial cell types and transitions in response to cardiac injury, we applied unbiased single-cell RNA sequencing (scRNA-seq) to profile the progression of gene expression patterns in cardiac interstitial cells through the three main phases of post-MI response: inflammation, proliferation, and maturation. Analysis of multiple closely spaced time points immediately after MI revealed a rapidly changing landscape of interstitial cell types, providing a detailed and comprehensive characterization of cellular features and building a precise map of stromal cell evolution in response to injury.

Given the dramatic differences in myocardial response to infarction among genetically diverse mice ([@bib68]), we analyzed two inbred strains, C57BL/6J and 129S1/SvImJ, to define distinct cellular features at the transition between inflammatory and proliferative phases, when the two strains display major differences in the incidence of early rupture (23% versus 59%, respectively). These studies reveal significantly different fibroblast states in hearts that are genetically prone to post-MI rupture, pinpointing specific cell populations that define reparative outcome in the damaged myocardium, which represent promising targets for anti-fibrotic treatments of heart failure.

Results {#sec2}
=======

Single-Cell Analysis Defines the Interstitial Cell Landscape Post-MI {#sec2.1}
--------------------------------------------------------------------

To profile cell dynamics in response to MI, we performed unbiased scRNA-seq on live nucleated interstitial cells using the 10X Chromium technology ([@bib91]). Since the epicardium, the mesothelium covering the heart, is the major source (∼80%) of cardiac fibroblasts in homeostasis ([@bib25], [@bib71]), we traced the stromal component using C57BL/6J *Wt1*^*Cre*^*;RosaZsGreen*^*f/+*^ mice, in which an enhanced green fluorescent protein (EGFP) variant (ZsGreen1) marks epicardial derivatives. To obtain a clean preparation of interstitial cells, we removed cardiomyocytes, debris, and dead cells by straining the cell suspension through 40-μm meshes using magnetic beads-based dead cell depletion and sorting for nucleated (DRAQ^+^) live (DAPI^−^) cells. A total of 36,847 live, nucleated interstitial cells were captured at homeostasis and at days (d) 1 and 3 (inflammatory phase), 5 and 7 (proliferative phase), and 14 and 28 (maturation phase) post-MI from 7 mice ([Figure 1](#fig1){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}; [@bib22]). Whole-mount images showed a diffuse ZsGreen fluorescence in homeostasis, which increased in intensity after injury, transiting from global heart activation (d1) to the border zone of the infarct (d3--d5) and onward into the scar area (d5--d28) ([Figure 1](#fig1){ref-type="fig"}B). ZsGreen^+^ cells increased in the late remodeling phase, indicating the presence of epicardial-derived cells in the mature scar ([Figure 1](#fig1){ref-type="fig"}C). Global clustering of single-cell transcriptomes ([@bib9], [@bib91]) revealed 16 main populations, identified by marker genes preferentially expressed in each cluster ([Figures 1](#fig1){ref-type="fig"}D--1G; [Table S2](#mmc3){ref-type="supplementary-material"}). These populations included endothelium (*Fabp4*, *Pecam1*); lymphatic endothelium (*Lyve1*, *Cldn5*); SMCs (*Rgs5*, *Vtn*, *Kcnj8*); Schwann cells (*Plp1*, *Kcna1*); 7 immune cell populations (granulocytes \[*S100a8*, *S100a9*\], monocytes I \[*Chil3*, *Plac8*\] and II \[*Saa3*, *Arg1*\], macrophages \[*C1qa*, *Cd68*\], dendritic cells \[DCs; *H2ab1*, *Cd74*\], B cells \[*Cd79a*, *H2-DMb2*\], and a mixed T-natural killer \[NK\] cell cluster \[*Nkg7*, *Ms4a4b*, *Gzma*\]); three fibroblast populations (types I \[*Col1a1*, *Gsn*, *Dcn*\], II \[*Wif1*, *Dkk3*\], and III \[*Mt2*, *Timp1*\]); myofibroblasts (Myofb; \[*Cthrc1*, *Acta2*, *Postn*\]); and epicardium (*Clu*, *Dmkn*)---all of these are described in more detail in [Figures 1](#fig1){ref-type="fig"}D and 1E.Figure 1Single-Cell RNA-Seq of Interstitial Cells Post-MI Reveals Population Dynamics in Cardiac Repair(A) Murine cardiac interstitial cells were isolated by mechanical and enzymatic dissociation of adult mouse cardiac ventricular tissue (dashed square); mesh purification, magnetic dead cell depletion, and sorting were performed to exclude cardiomyocytes and apoptotic or necrotic cells before analysis. A total of 38,600 cells were captured and sequenced (n = 7 mice).(B) Selected time points and whole-mount images of *Wt1*^*cre*^*;ZsGreen*^*f/+*^ mice used to trace epicardial-derived components in the cardiac interstitium.(C) Percentage of single live nucleated ZsGreen^+^ interstitial cells detected by flow cytometry in the samples used for scRNAseq. Data shown as mean ± SD of two technical replicates at each time point.(D) t-Distributed stochastic neighbor embedding (t-SNE) plot of the aggregate of all sequenced cells across time points. Seurat analysis with 24 PC and resolution 0.5 was used to define 16 main clusters.(E) Dot-plot visualization of top marker genes used to identify clusters. Dot sizes denote percentage of expression per cluster; color gradient defines average expression per cell.(F) t-SNE plot showing cell contribution by time point identified by color.(G) Bar plot of percentage of cluster contributions per time point.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.

*ZsGreen* expression marking epicardial origin was predominant in five clusters: epicardium, smooth muscle, and fibroblast types I--III ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}A). Co-expression of *Wt1* and *ZsGreen* marked a minor percentage of endothelial (∼1%) and smooth muscle (∼2%) cells, as well as the activated post-MI epicardium, indicating *de novo* expression of the gene, verified using immunofluorescence ([Figures S1](#mmc1){ref-type="supplementary-material"}B--S1D). No *de novo* expression of *Wt1* mRNA was seen in fibroblasts, confirming that post-MI activated fibroblasts derive from the pre-existing *Wt1*^*Cre*^*;RosaZsGreen*^*f/+*^ labeled pool of cells.

A dynamic and choreographed contribution of cell types evolved during infarct resolution ([Figures 1](#fig1){ref-type="fig"}F and 1G). Innate immune cells accumulated immediately after MI ([Figures 1](#fig1){ref-type="fig"}D--1G): short-lived neutrophils peaked within 24 h ([@bib22]), monocytes appeared between d1 and d7, and macrophages peaked ∼d3--d7. Cell ratios returned to near-homeostatic levels during the maturation phase of MI (d14--d28), with fibroblasts and endothelial cells prevailing over immune components ([Figure 1](#fig1){ref-type="fig"}G). Whereas a significant fraction of new cell types and states were observed in the stromal and innate immune cell aggregates during recovery from MI, adaptive immune and vascular/mural cells were relatively stable ([Figure S2](#mmc1){ref-type="supplementary-material"}).

Dynamics of Stromal Populations Involved in Scar Formation {#sec2.2}
----------------------------------------------------------

To obtain a more detailed portrait of stromal transition from homeostasis ([@bib24], [@bib62], [@bib70]) to post-MI response, fibroblast types I--III, Myofb, and mesothelial epicardial populations were aggregated and sub-clustered. Twelve sub-clusters were obtained ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S3](#mmc1){ref-type="supplementary-material"}, and [S4](#mmc1){ref-type="supplementary-material"}; [Table S3](#mmc4){ref-type="supplementary-material"}). Cellular trajectories were defined using SPRING ([@bib85]) (links to SPRING visualization in [Figure S2](#mmc1){ref-type="supplementary-material"}C). Predictions using DoubletFinder ([@bib55]) revealed an overall very low percentage of predicted doublets across clusters and sub-clusters ([Figure S3](#mmc1){ref-type="supplementary-material"}). Three clusters were excluded from further analyses due to low cell representation or mixed identity: a small cluster defined by interferon-response (IFNr) genes (*Ifit3*, *Isg15*, *Ifit1*), a few dendritic-like cells (*Cd52*, *C1qb*) with a relatively higher frequency of predicted doublets (0.5%; [Figure S3](#mmc1){ref-type="supplementary-material"}) compared to other clusters and sub-clusters, and phagocytic cells (mixed myeloid-Myofb signature; *Actb*, *Notch2*, *Lyz2*, *P2y12*). The latter cells were enriched during the post-MI proliferative phase (d3--d7) and were transcriptionally similar to proliferating Myofb ([Figure S4](#mmc1){ref-type="supplementary-material"}B), presenting a relatively higher expression of genes involved in metabolic processes and oxidative phosphorylation ([Figures 2](#fig2){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}).Figure 2Evolution of Fibroblast States across Phases of Repair(A) t-SNE plot of combined stromal clusters (fibroblasts I, II, and III, myofibroblasts) and epicardium, further sub-clustered by 20 PC, resolution 0.5, colored by cluster separation.(B) Bar plot representation of the relative frequency of different fibroblast sub-clusters (percentage over total cells) at different time points across repair.(C) Dot-plot representation of top two signature genes per sub-cluster.(D) SPRING visualization of fibroblast sub-clusters; 1,200 cells are shown per time point, colored by Seurat-defined clusters.(E) PANTHER GO-slim biological process overrepresentation analysis of fibroblasts sub-cluster marker genes, showing representative GO terms per each sub-cluster, excluding DCs, dendritic-like cells, and IFNr (interferon-responsive cells). Bonferroni corrected p values.See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

Within the type I fibroblast population, three closely related populations of ZsGreen^+^ epicardial-derived fibroblasts (EpiDs) were obtained and defined, based on temporal prevalence and/or marker expression, as homeostatic epicardial derived fibroblasts (HEpiDs), progenitor-like state fibroblasts (PLSs), and late-resolution (LR) fibroblasts. HEpiDs were characterized by a relatively higher level of expression of genes associated with the response to organic substances and metabolic effectors: *Dpep1,* a zinc-dependent metalloproteinase involved in glutathione and leukotriene metabolism, which may have a role in transforming growth factor β (TGF-β)-induced epithelial-mesenchymal transition (EMT) ([@bib60]); *Lpl*, important for lipoprotein triglyceride metabolism ([@bib19], [@bib88]); *Hsd11b1*, which converts cortisol to its inactive form, cortisone, and may affect dermal fibroblast proliferation ([@bib79]); and the pleiotropic chemokine *Cxcl14* ([@bib31], [@bib50]; [Figures 2](#fig2){ref-type="fig"}C--2E and [S4](#mmc1){ref-type="supplementary-material"}C). PLSs were relatively stable across all time points ([Figure 2](#fig2){ref-type="fig"}B), expressed genes associated to cell migration and morphogenesis, known stromal cell markers *Cd248* ([@bib72]), *Pi16* ([@bib64], [@bib88]), and relatively higher levels of *Ly6a*, previously used as a marker to enrich for putative cardiac progenitor cells ([@bib77], [@bib18], [@bib59]; [Figures 2](#fig2){ref-type="fig"}C--2E and [S4](#mmc1){ref-type="supplementary-material"}C). LR fibroblasts were prevalent at d14--d28 (maturation phase), expressing a relatively higher level of genes associated with cell differentiation, osteogenesis, and regulation of matrix remodeling and deposition, including *Adamtls2* and *Cilp,* secreted proteins involved in the negative regulation of TGF-β availability ([@bib45]) and activity ([@bib90]), fibrillogenesis ([@bib42]), and fibrosis ([@bib82], [@bib90]); *Col8a1,* an extracellular matrix (ECM) component conferring tensile strength that supports vessel integrity and structure ([@bib40]) upregulated in the presence of vascular injury ([@bib29], [@bib40], [@bib48]); and the transcription factor *Meox1*, which is involved in embryonic somitogenesis and TGF-β-induced differentiation of SMCs ([@bib16]; [Figures 2](#fig2){ref-type="fig"}C--2E and [S4](#mmc1){ref-type="supplementary-material"}C). *Meox1* is also implicated in cardiac pathological hypertrophy ([@bib51]) and is downregulated during *in vitro* phenoconversion from fibroblasts to Acta2^+^ Myofb ([@bib12]). The observed gene expression pattern of LR fibroblasts and their prevalence during the maturation phase suggests that these cells arise as a consequence of chronic pathological remodeling rather than as direct precursors of Acta2^+^ Myofb, as was recently suggested ([@bib18]).

The SPRING k-nearest neighbor (knn) graphical representation of stromal cells showed a linear progression from EpiD ZsGreen^+^ to Myofb ([Figure 2](#fig2){ref-type="fig"}C). Type II fibroblasts (*Wif1*, *Dkk3*) appeared as a distinct sub-cluster, branching separately in the SPRING plot ([Figure 2](#fig2){ref-type="fig"}D) and characterized by a gene signature closely related to valve leaflets, with top canonical pathways involved in endochondral ossification and Wnt signaling and Gene Ontology (GO) terms related to anatomical structure morphogenesis and development ([Figures 2](#fig2){ref-type="fig"}C--2E, [3](#fig3){ref-type="fig"}E, and [S4](#mmc1){ref-type="supplementary-material"}C). Given the low level of ZsGreen expression in these cells, possibly due to ambient RNA contamination, they are likely endocardial-derived fibroblasts (EndD). Consistently, 88.5% ± 2.27% of the DKK3^+^ cells in the ventricles were co-labeled with ZsGreen in *Tek*^*Cre*^*;ZsGreen*^*f/+*^ mice (which trace endocardial-derived cells), while 88.05% ± 4.02% of EndD cells were ZsGreen^−^ in *Wt1*^*Cre*^*;RosaZsGreen*^*f/+*^ mice ([Figure 3](#fig3){ref-type="fig"}). A similar population, recently referred to as Wnt-X ([@bib18]), was considered an activated state, since WIF1 protein was observed immediately after injury in the peri-infarct area ([Figure S4](#mmc1){ref-type="supplementary-material"}D). In contrast, our analysis showed the expression of the signature marker DKK3 already in homeostasis around coronary vessels and valve fibroblasts ([Figure 3](#fig3){ref-type="fig"}), suggesting that the segregation of the EndD as a sub-population of fibroblasts may be due to its embryological origin, rather than to an activation state ([Figure 2](#fig2){ref-type="fig"}D).Figure 3Endocardial-Derived Fibroblast (EndD) Validation in Homeostatic Ventricles(A) Confocal imaging of the EndD marker DKK3 (in red) on cardiac sections from adult *Wt1*^*Cre*^*; ZsGreen*^*f/+*^ mice. ZsGreen labels epicardial derived cells.(B) Quantification of the percentage of DKK3^+^ cells co-labelled with the reporter ZsGreen. Data are represented as mean ± SEM. N = 3 biological replicates, 7 technical replicates.(C) Confocal imaging of DKK3 (in red) on cardiac sections from adult *Tek*^*Cre*^*; ZsGreen*^*f/+*^ mice. ZsGreen labels endocardial-derived cells.(D) Quantification of the percentage of DKK3^+^ cells co-labelled with the reporter ZsGreen. Data are represented as mean ± SEM. N = 3 biological replicates, 7 technical replicates.(E) Enrichr analysis of EndD marker genes identified top related cell (mouse gene atlas) and tissue (ARCHS4 tissues) types.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

A sub-cluster of ZsGreen^+^ EpiD cells, defined by its injury response (IR) properties, and expressing high levels of *Mt1-2* transcripts ([Figures 4](#fig4){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}B), appeared at d1, preceding Myofb at d3 ([Figure 2](#fig2){ref-type="fig"}B). MT1-2 metallothioneins are involved in the alleviation of oxidative stress and immunomodulation ([@bib74]), and transient *Mt1-2* activation in stress conditions or inflammatory diseases ([@bib13]) exerts a protective function by reducing apoptosis and excessive fibrosis ([@bib17]). The IR sub-cluster also showed a high expression of monocyte-macrophage chemoattractants *Ccl2*, *Ccl7*, and *Csf1* and neutrophil activators *Cxcl1* and *Cxcl5*; pro-inflammatory-pro-fibrotic factors *Il33*, *Cxcl12*, and *Tgfb1* ([Figure 4](#fig4){ref-type="fig"}B); the metalloprotease inhibitor *Timp1,* which blocks *Mmp1* but can additionally prevent apoptosis and induce proliferation in a range of cell types ([@bib8]); the *Mmp3* metalloprotease, which can degrade the major components of the ECM but not interstitial collagen I ([@bib49]); and matricellular proteins with pro-inflammatory or pro-reparative functions such as *Prg4* ([@bib33]) and *Angptl4* ([@bib35], [@bib78]). This complex cocktail of regulatory factors implicates the IR cell cluster in the initiation of the inflammatory response and formation of granulation tissue. GO biological terms and canonical pathways associated with this cluster included ribosome biogenesis; regulation of eukaryotic translation initiation factor 2 (eIF2), eIF4, and p70S6K, indicating active protein synthesis and translation; and acute phase response signaling (*Serpina3n*, *Serpina1*, *Tnfrsf1a*), involved in the unfolded protein response and glycolysis ([Figures 2](#fig2){ref-type="fig"}E and [4](#fig4){ref-type="fig"}C). To confirm the expression of MT1-2 in stromal cells, immunostaining was performed on *Wt1*^*cre*^*;ZsGreen*^*f/+*^, to verify the epicardial origin, and *Col1a1*^*eGFP*^ mice, for quantification. While in homeostasis, MT1-2 proteins were expressed mostly in CD45^+^ cells (88.9% ± 5.4% of CD45^+^ cells, 4% ± 1.3% of Col1a1-EGFP^+^ cells; [Figures 4](#fig4){ref-type="fig"}D and 4E), reflecting their role in immune cell maturation ([@bib74]); global activation was detected at d1 in EpiD (ZsGreen^+^) stromal cells, extending from the injury site to remote myocardial areas (62.7% ± 2.5% of Col1a1-GFP^+^ cells [Figures 4](#fig4){ref-type="fig"}D and 4E). At d3, MT1-2^+^ stromal cells were reduced and mostly confined to the scar area (29.6% ± 5% of Col1a1-GFP^+^ cells in the scar area versus 6% ± 0.2% distal area), labeling a fraction of Myofb defined by anatomical position, morphology, and high expression of Col1a1-GFP. MT1-2^+^ was mostly limited to CD45^+^ and sub-epicardial cells at d5. Consistently, SPRING analysis showed that the IR cluster evolved from high expression of *Mt1-2* and stromal and fibroblast genes (*Gsn* \[[@bib87]\], *Pdpn* \[[@bib75]\], *Angptl4*) on d1 to low expression of *Mt1-2* accompanied by Myofb markers (*Fn1*, *Acta2*, *Cthrc1)* on d3 ([Figure 4](#fig4){ref-type="fig"}F), suggesting that IR cells rapidly transition to Myofb, in contrast to a previous report suggesting the appearance of Myofb not earlier than d7 post-MI ([@bib18]).Figure 4An Epicardial-Derived Injury Response (IR) Fibroblast Population in the Early Phase of Repair Post-MI(A) Heatmap of the average expression of the top 20 signature IR cluster genes across all fibroblast sub-clusters.(B) Top cytokines and chemokines produced by the IR cluster.(C) Top IR cluster canonical pathways identified using Ingenuity Pathway Analysis (IPA).(D) Confocal imaging of MT1-2 staining in IR fibroblasts at d1 and d3 post-MI using *Wt1*^*cre*^*;ZsGreen*^*f/+*^ and *Col1a1*^*eGFP*^ reporter mice.(E) Scatterplot showing the percentage of MT1-2^+^ cells co-labeled with the reporter *Col1a1*^*eGFP*^ or CD45 (gray). A total of 5--10 frames were counted per each time point, 2--3 mice per time point. Data are represented as means ± SEMs. LV (green dot) is the left ventricle injury site; RV/Distal (red triangle), right ventricle, area distal from the injury site.(F) SPRING visualization of the IR sub-cluster showing time course evolution of cluster identity (blue arrow) from fibroblast (Fb) to myofibroblast (Myofb). Plots on right panels show marker genes that distinguish early (Fb) from late (Myofb) IR cells. Scale bars, 50 μm.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

Myofb, large cells with highly active endoplasmic reticulum, are defined as specialized fibroblasts that appear post-injury, produce a high quantity of ECM components, and acquire some phenotypic and functional features of SMCs, such as contraction capacity upon stimulation, essential for the closure and stabilization of the injury site ([@bib5], [@bib22]). Our analysis showed a linear progression from EpiD ZsGreen^+^ to Myofb ([Figure 2](#fig2){ref-type="fig"}D). Three main populations of Myofb were observed post sub-clustering: Myofb (*Acta2*, *Cthrc1*), ProlifMyofb (*Acta2*, *Cthrc1*, cell-cycle genes) from d3 to d7, and a group of cells similar to the recently defined matrifibrocytes (MFCs) ([@bib23]) enriched in the mature scar (d14--d28). MFCs expressed genes related to osteoblasts and chondrocytes, similarly to EndD fibroblasts ([Figure 5](#fig5){ref-type="fig"}), such as cartilage oligomeric matrix protein (*Comp*), an ECM protein present in cartilage that catalyzes the assembly of collagens and formation of fibrils ([@bib30]), and genes associated with fibrosis and collagen signaling, similar to LR fibroblasts and Myofb. Pairwise differential gene expression analysis of all fibroblast states using Seurat revealed that, compared to EndD, MFCs had higher levels of ECM components (*Col8a1*, *Fn1*, *Fbn1*, *Itgbl1*, *Wisp2*, and *Cthrc1)* and notably did not express the Wnt inhibitor *Wif1* ([Figure S4](#mmc1){ref-type="supplementary-material"}C; [Table S4](#mmc5){ref-type="supplementary-material"}). Compared to Myofb, MFCs had reduced expression of genes associated with contractility (*Acta2*, *Tagln*, *Tpm2*, and *Myl9*) or ECM components (*Timp1*, *Tnc*, *Cthrc1*, and *Col1a1*), but expressed *Comp* and *Angptl7* and *Fbln1* and *Cilp*, supporting the transition to a less contractile, less secretory cell type producing components of a more stable, chondrogenic-like ECM.Figure 5Contribution of Myofibroblasts (*Myofb*), Matrifibrocytes (*MFCs*), and Late Response Fibroblasts (*LR*) to Ventricular Remodeling Post-MI(A) knn SPRING visualization of the Myofb cluster identified from analysis of the stromal aggregate across 7 time points (PC24, resolution 0.5), colored by time and by the expression of early *Myofb* marker genes (*Acta2*, *Tnc*, *Cthrc1*, light blue) and *MFC* marker genes (*Sfrp2*, *Clu*, *Ecrg4*, *Comp*, *Wisp2*, *Thsb4)*.(B and C) Confocal imaging of adult hearts from *Col1a1*^*eGFP*^ mice, used as a genetic marker for stromal cells. (B) *Myofb* markers CTHRC1 (red) and ACTA2 (white) and (C) *MFC* markers SFRP2 (red) and CLU (white) at different time points post-MI.(D) qPCR validation of additional *Myofb* (light blue), *MFC* (dark blue), and *LR* (olive green) markers on live nucleated stromal cells (PI^−^, DRAQ5^+^, EGFP^+^) sorted from *Col1a1*^*eGFP*^ transgenic hearts. Scar or distal areas were dissected and separately processed for sorting from control (n = 3) or d5 (n = 3) and d14 (n = 3) post-MI ventricular tissue.Data are summarized as box and whisker plots, indicating the median value (black bar inside box), 25th and 75th percentiles (bottom and top of box, respectively), and minimum and maximum values (bottom and top whisker, respectively). Statistical significance (^∗^p \< 0.05, ζp \< 0.001, \#p \< 0.0001) was calculated per each gene by two-tailed unequal variance Student's t test between sample (distal d5, distal d14, scar d5) and correspondent reference used for normalization (distal d0, scar d14). Scale bars, 50 μm.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

To visualize the conversion between these two cell types in the injury site, immunofluorescence was performed using ACTA2 and CTHRC1 as Myofb markers. MFC markers included SFRP2, a pro-reparative paracrine factor ([@bib58]), and CLU, a widely expressed glycoprotein upregulated in senescent fibroblasts or under different stress conditions. CLU may play a role in apoptosis, debris removal, and folding of secreted proteins ([@bib36], [@bib37]; [Figures 5](#fig5){ref-type="fig"}B and 5C). ACTA2 staining in Myofb was seen at a lower intensity than in SMCs starting from d3, and was mostly limited to vessels at d14--d28, while Myofb CTHRC1 staining persisted at late stages. In MFCs, SFRP2 and CLU staining increased at later stages; the latter was also expressed in activated endocardium and epicardium ([Figure 5](#fig5){ref-type="fig"}C). qPCR analysis on Col1a1-EGFP^+^ stromal cells isolated from the scar and distal myocardial areas of the heart at d5--d14 post-MI confirmed that Myofb markers *Acta2* and *Tnc* were significantly higher in the scar during the proliferation phase (d5), while MFC markers *Ecrg4*, *Comp*, *Sfrp2*, *Thbs4*, *Wisp2*, *Meox1*, and *Col8a1* were upregulated at d14. *Meox1*, *Comp*, *Ecrg4*, and *Col8a1* were unaltered or not significantly changed in the d5 distal area compared to the control, confirming their enrichment in LR fibroblasts. These results underscore the dynamic stromal response to cardiac injury, which induces a complex orchestration of multiple cell subtypes responsible for post-MI remodeling.

Genetically Determined Factors Confer Resilience to Cardiac Rupture {#sec2.3}
-------------------------------------------------------------------

Genetic background dictates differences in initial cardiac stromal cell composition that may influence the course of replacement fibrosis in cardiovascular disease ([@bib22], [@bib68]). Here, we took advantage of the genetic diversity across inbred mouse strains to investigate the variation in response to MI: C57BL/6J or B6J (control), 129S1/SvlmJ or 129 (prone to hypertension), DBA/2J (prone to calcification), NOD/ShiLtJ (prone to type 1 diabetes), NZO/HlLtJ (obese), A/J (prone to muscular dystrophy), and three wild-derived strains (CAST/EiJ, WSB/EiJ, and PWK/PhJ) ([Figure 6](#fig6){ref-type="fig"}A). The mortality rate varied among strains, with 129 showing the highest rate of rupture (59%; n = 34) when compared to B6J (23%; n = 13), as previously described ([@bib27]). The baseline cardiac function of both lines was similar ([Figure S5](#mmc1){ref-type="supplementary-material"}), despite previous reports of higher blood pressure in 129 males ([@bib3]), attributed to the increased activity of the renin-angiotensin system (RAS) pathway ([@bib52], [@bib84]), which promotes inflammation ([@bib28]). Rupture occurred between d4 and d5 in B6J and d3 and d4 in 129 ([Figure S5](#mmc1){ref-type="supplementary-material"}K), similar to previous reports ([@bib27]) and coinciding with the transition from the inflammatory to the proliferative phase and of fibroblast state from IR to Myofb.Figure 6Differential Rupture Rate and Stromal Cell Response across Inbred Murine Strains(A) Pie charts showing 1-month survival rate post-MI of 9 inbred strains with different susceptibilities to cardiovascular dysfunction, including diabetes (NOD/ShiLtJ, n = 13), obesity (NZO/HILtJ, n = 16), hypertension (129S1/SvlmJ, n = 34), calcification (DBA/2J; n = 9), dystrophic myopathy (A/J; n = 14), and wild-derived strains (CAST/EiJ, n = 18; WSB/EiJ, n = 12 and PWK/PhJ, n = 11). C57BL/6J was used as a control (n = 13).(B) Representative whole-mount images of 129S1/SvlmJ and C57BL/6J hearts at homeostasis and d3 post-MI.(C) t-SNE plot of combined interstitial cells from C57BL/6J and 129S1/SvlmJ hearts (B6J sham, n = 2, 4,710 cells; 129 sham, 4,213 cells; d3 MI B6J, 3,950 cells; d3 MI 129, 4,128 cells). Twenty-seven clusters were obtained using unbiased clustering.(D) Relative ratio of various stromal cell populations in 129 and B6J hearts at d3 sham or MI (mean cells per thousand). Two B6J sham samples were used to show consistency between biological replicates.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc6){ref-type="supplementary-material"}.

To understand how differences in cell composition and/or gene expression may determine the higher propensity to rupture in 129, scRNA-seq of 129 and B6J cardiac interstitial cells were compared in sham-operated mice and at d3 post-MI ([Figure 6](#fig6){ref-type="fig"}B), the crucial pre-rupture time point. Data were integrated, using Harmony, an algorithm that projects cells into a shared embedding while accounting for a biological variable---in this case, genetic background ([@bib43]; [Figure 6](#fig6){ref-type="fig"}C). The comparison to sham-operated mice that were subjected to a similar procedure, with chest opening and tearing of the pericardium, allowed us to focus on the differences caused by the ischemic injury alone. Post-MI 129 hearts presented relatively more Myofb, ProlifMyofb, and IR fibroblasts than B6J ([Figure 6](#fig6){ref-type="fig"}D), at the expense of other fibroblast states, which were balanced or relatively reduced in 129 ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B).

Within the stromal cluster aggregate ([Figure S6](#mmc1){ref-type="supplementary-material"}C), 3,922 genes were differentially expressed between 129 and B6J as a function of strain and MI ([Tables S6](#mmc7){ref-type="supplementary-material"} and [S7](#mmc8){ref-type="supplementary-material"}). PANTHER analysis defined differences in pathways related to inflammation, receptor tyrosine kinase signaling, cell migration, ECM organization, and collagen formation between strains ([Figures 7](#fig7){ref-type="fig"}A, [S7](#mmc1){ref-type="supplementary-material"}A, and S7B). Ingenuity Pathway Analysis (IPA) confirmed the enrichment in pathways related to fibrosis, adhesion, growth, and inflammation, and predicted upstream regulators, including pro-inflammatory and pro-fibrotic factors (*Tgfb1*, *Tnf*, *Ifng*, *Il1b*, *Il4*, *Agt*) ([Figure S8](#mmc1){ref-type="supplementary-material"}). The expression of genes within GO categories for ossification, ECM organization, ECM structural components, and collagen-containing matrix were relatively reduced in 129 sham, but upregulated in 129 at 3d post-MI compared with B6J ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7D). Within ECM components, elasticity genes (*Eln*, *Emilin2*, fibulins, microfibrillar-associated proteins) were relatively lower in 129 irrespective of injury ([Figure 7](#fig7){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}D), while tensile-strength collagens (*Fn1*, *Tnc*, *Thbs1*, *Vcan)* were upregulated in 129 post-MI. ECM-associated enzymes (*Adamts2*, *Adamts5*, *Lox*, *Loxl2*, *Bmp1)* were also higher in 129 post-MI, while metalloproteinases were increased in B6J ([Figures S8](#mmc1){ref-type="supplementary-material"}C and S8D), with the exception of *Mmp9*, or gelatinase B, which was previously associated with cardiac rupture ([@bib81]), and *Mmp14*, a membrane-associated metalloprotease involved in the activation of MMP2, or gelatinase A ([@bib38]). ECM components involved in the inflammatory response (*Hif1a*, *Timp1*, *F2r*) were upregulated in 129 post-MI ([Figures 7](#fig7){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}E), as well as coagulation genes *(F2r*, *Pf4*) and negative regulators of fibrinolysis (*Serpine1*, *Thbs1)* ([Figure 7](#fig7){ref-type="fig"}D). Mouse strain 129 also expressed relatively higher levels of acute phase response genes (*Tlr4*, *Serpina3n*, *Saa3)* both in sham and post-MI, and increased chemoattractant or chemokine activity post-MI, with the exception of *Cxcl14,* which was already higher in 129 sham ([Figures 7](#fig7){ref-type="fig"}D and [S7](#mmc1){ref-type="supplementary-material"}E).Figure 7Differential Pro-inflammatory and Secretory Phenotypes and ECM Composition between 129 and B6J Cardiac Stromal Cells(A) PANTHER Reactome pathway analysis of 3,922 differentially expressed genes (FC ≥ 2; p \< 0.01) between sham or d3 post-MI 129 and B6J stromal cells.(B--D) Dot plots showing the percentage and intensity of expression of genes within representative GO terms related to angiotensin response (B), ECM composition (C), and acute phase response and coagulation (D) across all of the samples. Two B6J sham samples were used to show consistency of change between biological replicates. Percentage scores denote the number of genes within the GO term that are represented in the list of differentially expressed genes.(E) qPCR validation of gene changes across samples. Sorted CD45^−^/CD31^−^ stromal cells were isolated from adult 129 and B6J d3 sham or post-MI hearts (n = 3 biological and technical). Target genes were grouped as *Myofb* markers, ECM components, genes regulating ECM composition, coagulation, acute phase response, chemokine activity, and renin-angiotensin system (RAS).Data are summarized as box and whisker plots, indicating the median value (black bar inside box), 25th and 75th percentiles (bottom and top of box, respectively), and minimum and maximum values (bottom and top whisker, respectively). Statistical significance (^∗^p \< 0.05, ζp \< 0.001, \#p \< 0.0001) per each gene was calculated by two-tailed unequal variance Student's t test, comparing expression values in 129 versus B6J reference samples used for normalization.See also [Figures S7--S9](#mmc1){ref-type="supplementary-material"} and [Tables S6](#mmc7){ref-type="supplementary-material"} and [S7](#mmc8){ref-type="supplementary-material"}.

Among its numerous functions, the RAS is involved in ECM deposition through stimulation of the AgtR1 ([@bib56]). Angiotensin II (AngII) induces a secretory phenotype in fibroblasts, stimulating the production of chemokines and ECM components ([@bib7]), as well as pro-fibrotic factors, including TGF-β1 ([@bib66]). AngII plays an essential role in promoting liver fibrosis by upregulating Toll-like receptor 4 (TLR4), thus enhancing downregulation of the TGF-β1 inhibitory pseudo-receptor BAMBI ([@bib46]). Consistently, our single-cell data showed a relative increase in *Agt1ra*, its downstream targets *Tlr4*, *Tgfb1*, and *Ctgf* ([Figure 7](#fig7){ref-type="fig"}B), and reduced *Bambi* in 129 stromal cells post-MI ([Figures S8](#mmc1){ref-type="supplementary-material"}C and [S9](#mmc1){ref-type="supplementary-material"}).

In summary, the increased susceptibility of 129 hearts to rupture is associated with persistent coagulation and impaired fibrinolysis that increases instability in the injury site, which is also supported by the higher responsiveness to angiotensin ([Figures 7](#fig7){ref-type="fig"}B, [S7](#mmc1){ref-type="supplementary-material"}B, and [S9](#mmc1){ref-type="supplementary-material"}). The increased production of ECM components in 129 post-MI does not confer resilience to rupture; rather, other ECM properties, such as fiber alignment, or physiological differences in baseline ECM composition, have been suggested as critical factors for heart repair following injury ([@bib26], [@bib65], [@bib68]).

Discussion {#sec3}
==========

In the heart, interstitial cells of varying identities provide important regulatory functions in tissue homeostasis and repair, and an accurate evaluation of their composition is essential for defining their respective roles during pathogenesis and for devising strategies for tissue engineering and other therapeutic intervention. Our previous studies offered insights on the abundance and characteristics of different interstitial cell types in the heart, aided by isolation strategies and genetic tools to define and manipulate fibroblasts ([@bib24]), refined flow cytometry techniques ([@bib61], [@bib62]), and unbiased single-cell analysis ([@bib70]) in the absence of cardiomyocytes, without relying on surface markers that may overlap different cell states and conceal heterogeneity ([@bib1], [@bib34]). We also drew on recent work leveraging mouse genetic diversity for the discovery of the gene networks associated with variations in cardiovascular disease outcomes ([@bib68]).

The inclusion of a genetic reporter distinguished multiple EpiD subtypes (HEpiD, PLS, LR, IR, Myofb, MFC) whose sequential appearance defined post-MI phases, as well as an endocardial-derived cell population (EndD) expressing genes involved in endochondral ossification and Wnt signaling inhibition, whose stable presence in homeostasis persisted throughout repair. Detailed profiling of the dynamic transcriptional changes across three phases of cardiac response to infarction (inflammatory, proliferative, and maturation) revealed a rapid induction of dynamic injury-induced transitions in interstitial cell states, including an emerging fibroblast subset associated with inflammatory initiation that marked the inherited characteristics of pathogenic outcomes.

In contrast to previous scRNA-seq studies in cardiac post-ischemic injury ([@bib18], [@bib44]), the analysis of multiple time points (d1, d3, d5, d7) immediately post-MI has provided a higher resolution of the early dynamic transitions in stromal cells that predict survival versus cardiac rupture. Whole-heart activation soon after injury identified an IR signature in fibroblasts and in a fraction of early Myofb, expressing molecular markers of oxidative stress alleviation and immunomodulation. A detailed analysis of the proliferative phase (d3, d5, d7) revealed a prevalence of Myofb and their cycling counterparts (ProlifMyofb) and a phagocytic population with mixed fibroblastic-myeloid identity ([@bib2]). Profiles of later post-MI stages (d14, d28) identified a population of EpiD (LR), expressing genes modulatory of TGF-β activity and availability and regulatory of ECM components involved in tissue remodeling and pathological hypertrophy. A similar cell type (F-actin) has been recently defined as a pre-Myofb activation state in which fibrosis is inhibited ([@bib18]). Given that LR are prevalent in the distal infarct area during the maturation phase, when Myofb are replaced by MFC derived from Acta2^+^ cells ([@bib23]), LR are most likely not direct Myofb precursors, but rather a state indicative of chronic remodeling. Our current analysis confirmed that MFCs are closely related to Myofb ([@bib23]), but have reduced contractile and secretory properties, expressing different matrix components associated with late remodeling and ossification.

The early transition of IR to Myofb is likely an important step in determining reparative outcome, considering the high prevalence of cardiac rupture in 129 hearts in the early proliferative phase (d3--d4). Clear differences in the stromal compartment of 129 hearts showed a prevalence of Myofb and IR Myofb, with a stronger pro-inflammatory and secretory state, including increased production of chemokines, inflammatory signals, and ECM components, as compared to B6J hearts. This phenotype is correlated with an enhanced response to angiotensin. A high responsiveness to the RAS pathway may be due to the presence of a duplication of the Renin gene in the 129 strain, the function of which is still not completely clear ([@bib52], [@bib84]). Treatments with therapeutic drugs targeting the RAS pathway cause a significant reduction in the frequency of rupture in 129, independently from changes in blood pressure, and attributed to reduced inflammatory infiltration ([@bib28]). Here, significant differences in the single-cell transcriptomic analysis, combined with bulk qPCR validation in the stromal compartment of the 129 mice, are in line with the pleotropic functions of angiotensin, which not only regulates the recruitment of myeloid cells from the spleen ([@bib76]) but also promotes fibrosis and collagen deposition by fibroblasts ([@bib47], [@bib56]). While it may seem paradoxical that mice with more ECM-secreting Myofb are prone to rupture, the reduced expression of collagens and ECM components conferring elasticity in 129 homeostatic hearts suggest that pre-existing scaffolds are more important than newly secreted matrices in conferring resistance to rupture ([@bib26]). An alternative explanation for this phenomenon is that the quality, organization, and maturation of the matrix is more important than its pure enhanced secretion. In addition, gene expression patterns indicate that persistent coagulation and reduced fibrinolysis in 129 may contribute to the instability of the injury site.

The 129 model resembles the more common cardiac rupture of the pre-reperfusion era (type III), characterized by transmural myocardial necrosis with hemorrhagic transformation in the central region ([@bib6]). The present study pinpoints the modulation of the early transition from IR to Myofb as a critical determinant for risk of rupture and pathological remodeling in the 129 model and proffers mechanistic insights into the previously reported beneficial effects of fibrinolytic and anti-RAS therapies in these patients ([@bib4], [@bib32]). It presents a comprehensive profile of cell types and pathways for the modulation of fibrosis as a critical intervention post-MI, providing potential targets for anti-fibrotic intervention. The detailed transcriptomic analysis of cardiac interstitial cells at different time points post-MI provides a benchmark for comparative analyses of potential differences in cell composition and dynamics of genetically diverse models with different reparative outcomes. Future mapping of the networks controlling the fibroblast IR state promises to identify specific features conferring susceptibility and resilience to cardiac rupture, enabling patient stratification and the development of precision therapies.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit monoclonal anti-Wilms Tumor ProteinAbcamCat\# ab89901; RRID: [AB_2043201](nif-antibody:AB_2043201){#intref0010}Goat polyclonal anti-mouse Dkk3R&D SystemsCat\# AF948; RRID: [AB_355734](nif-antibody:AB_355734){#intref0015}Rabbit polyclonal anti-CTHRC1Thermo Fisher ScientificCat\# PA5-49638; RRID: [AB_2635092](nif-antibody:AB_2635092){#intref0020}Mouse Monoclonal Anti- alpha-Smooth Muscle antibodySigma-AldrichCat\# A5228; RRID: [AB_262054](nif-antibody:AB_262054){#intref0025}Mouse Monoclonal Anti-Metallothionein Antibody, Clone UC1MTEnzo Life SciencesCat\# ADI-SPA-550-D; RRID: [AB_2039383](nif-antibody:AB_2039383){#intref0030}Rat monoclonal anti-CD45 (Leukocyte Common Antigen, Ly-5) antibodyBD BiosciencesCat\# 550539; RRID: [AB_2174426](nif-antibody:AB_2174426){#intref0035}Rabbit Polyclonal anti-CLU, clone RB18701MyBioSourceCat\# MBS9215265Rat monoclonal anti-Sfrp2, Clone 331022R&D SystemsCat\# MAB1169; RRID: [AB_2187093](nif-antibody:AB_2187093){#intref0040}Donkey anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 568Thermo Fisher ScientificCat\# A-11057; RRID: [AB_2534104](nif-antibody:AB_2534104){#intref0045})Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 568Thermo Fisher ScientificCat\# A-11031; RRID: [AB_144696](nif-antibody:AB_144696){#intref0050}Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat\# A-21247; RRID: [AB_141778](nif-antibody:AB_141778){#intref0055}Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat\# A-21241; RRID: [AB_2535810](nif-antibody:AB_2535810){#intref0060}Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat\# A-21244; RRID: [AB_2535812](nif-antibody:AB_2535812){#intref0065}Anti-Mouse CD32/CD16 - Purified Functional Grade; Clone 2.4G2 antibodyLeinco TechnologiesCat\# C381; RRID: [AB_2737484](nif-antibody:AB_2737484){#intref0070}APC/Cyanine7 anti-mouse CD45 antibodyBioLegendCat\# 103115; RRID: [AB_312980](nif-antibody:AB_312980){#intref0075}PE-Cy7 Rat Anti-Mouse CD31 Clone 390 (RUO)BD BiosciencesCat\# 561410; RRID: [AB_10612003](nif-antibody:AB_10612003){#intref0080}**Chemicals, Peptides, and Recombinant Proteins**DRAQ5eBioscienceCat\# 65-0880-92Propidium IodineSigma-AldrichCat\# P4864DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)Thermo FisherCat\# D1306; RRID: [AB_2629482](nif-antibody:AB_2629482){#intref0085}**Critical Commercial Assays**10x Chromium system using version 2 chemistry10x ChromiumCat\# CG00052RNAqueous-Micro Total RNA Isolation KitThermo FisherCat\# AM1931SuperScript IV VILO Master Mix with ezDNase EnzymeThermo FisherCat\#11766050Dead Cell Removal MicroBeadsMiltenyi BiotecCat\# 130-090-101**Deposited Data**Genome Reference Consortium Mouse Build 38NCBIGRCm38/mm10129 reference genomeThis paper using g2gtoolsN/AGene Ontology terms databaseMouse Genome Informatics (MGI)<http://www.informatics.jax.org/downloads/reports/gene_association.mgi.gz>scRNaseq data from this paperArray Express repositoryArrayExpress: E-MTAB-7895ZsGreen coding sequenceRRID: Addgene_22798**Experimental Models: Organisms/Strains**Mouse: B6.Cg-Gt(ROSA)26Sor^tm6(CAG-ZsGreen1)Hze/J^The Jackson LaboratoryJAX: 007906Mouse: Tg(Wt1-cre)\#Jbeb[@bib14], [@bib86]MGI: [5308608](mgi:5308608){#intref0095}Mouse: B6.Cg-Tg(Tek-cre)12Flv/JThe Jackson LaboratoryJAX: 004128Mouse: Tg(Col1a1-EGFP)\#Dab[@bib89]MGI: [4458034](mgi:4458034){#intref0100}Mouse: NZO/HlLtJThe Jackson LaboratoryJAX:002105Mouse: WSB/EiJThe Jackson LaboratoryJAX: 001145Mouse: NOD**/**ShiLtJThe Jackson LaboratoryJAX: 001976Mouse: 129S1/SvImJThe Jackson LaboratoryJAX: 002448Mouse: PWK/PhJThe Jackson LaboratoryJAX: 0003715Mouse: CAST/EiJThe Jackson LaboratoryJAX: 000928Mouse: A/JThe Jackson LaboratoryJAX: 000646Mouse: C57BL/6JThe Jackson LaboratoryJAX: 000664Mouse: DBA/2JThe Jackson LaboratoryJAX: 000671**Oligonucleotides**Primers designed for this study; see [STAR Methods](#sec4){ref-type="sec"} and [Method Details](#sec4.4){ref-type="sec"}This paperN/APrimers for HPRT[@bib24]N/APrimers for Rpl4[@bib67]N/A**Software and Algorithms**Vevo LAB softwareFUJIFILM/VisualSonics Inc., Canada<https://www.visualsonics.com/product/software/vevo-lab>CellRanger v2.110x Genomics<https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/installation>STAR aligner[@bib15]STAR; RRID:[SCR_015899](rridsoftware:SCR_015899){#intref0115}g2gtools[@bib39]<https://github.com/churchill-lab/g2gtools>R version 3.4.1[@bib63]<https://cran.r-project.org/bin/macosx/>Seurat software package version 2.3.4[@bib9], [@bib53]Seurat; RRID:[SCR_016341](rridsoftware:SCR_016341){#intref0130}SPRING[@bib85]<https://kleintools.hms.harvard.edu/tools/spring.html>DoubletFinder[@bib55]<https://github.com/chris-mcginnis-ucsf/DoubletFinder>Harmony R package version 0.0.0.9000[@bib43]<https://omictools.com/harmony-2-tool>MAST software[@bib20]MAST; RRID:[SCR_016340](rridsoftware:SCR_016340){#intref0150}Ingenuity Pathway AnalysisQIAGENIngenuity Pathway Analysis; RRID:[SCR_008653](rridsoftware:SCR_008653){#intref0155}Panther[@bib57]PANTHER, RRID:[SCR_004869](rridsoftware:SCR_004869){#intref0160}LAS software v4.8LeicaLeica Application Suite; RRID:[SCR_016555](rridsoftware:SCR_016555){#intref0165}Fiji version 1.0[@bib69]Fiji, RRID:[SCR_002285](rridsoftware:SCR_002285){#intref0170}LASXLeicaLeica Application Suite X; RRID:[SCR_013673](rridsoftware:SCR_013673){#intref0175}

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Elvira Forte (<elvira.forte@jax.org>). This study did not generate new unique reagents.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animal models {#sec4.3.1}

All animal procedures were approved by the JAX Institutional Animal Care and Use Committee (IACUC) under the license 16010 and comply with NIH regulations. For constitutive epicardial genetic tracing, males from the *Wt1*^*Cre*^ transgenic line ([@bib14], [@bib86]) were crossed with the reporter B6.Cg-Gt(ROSA)26Sor^tm6(CAG-ZsGreen1)Hze/J^ (named *ZsGreen*^*f/+*^ in this work; JAX stock \#007906) ([@bib54]). For constitutive endocardial genetic tracing, the same reporter was crossed with B6.Cg-Tg(Tek-cre)12Flv/J mice (*Tek*^*Cre*^; JAX stock \#004128) ([@bib41]). The previously described *Col1a1*^*eGFP*^ transgenic mice were used as a cardiac fibroblast marker for validation experiments ([@bib89]). Nine different inbred strains were subjected to myocardial infarction to evaluate the reparative outcome: NZO/HlLtJ (JAX stock \#002105), WSB/EiJ (JAX stock \#001145), NOD**/**ShiLtJ (JAX stock \#001976), 129S1/SvImJ (JAX stock \#002448), PWK/PhJ (JAX stock \#0003715), CAST/EiJ (JAX stock \#000928), A/J (JAX stock \#000646), C57BL/6J (JAX stock \#000664) and DBA/2J (JAX stock \#000671).

Method Details {#sec4.4}
--------------

### Myocardial infarction {#sec4.4.1}

Myocardial infarction was performed as previously described ([@bib68]) on young adult males (10-12-week-old.) Briefly, the left anterior descending branch of the coronary artery (LAD) was permanently ligated above branching, about 1mm below the tip of the left auricle. Only mice with \> 30% left ventricular ischemia were used for analysis. The mouse thoracic cavity was then closed and sutured. Sustained release 0.05 μg/g buprenorphine gel formulation was administered subcutaneously at the time of surgery for analgesia. Bipuvicane has administered locally to chest suture site. Mice were individually monitored daily for the first 7 days, followed by weekly monitoring until the endpoint of experiments. Survival rates were also assessed at 28 days. Myocardial rupture (days 3-5) was confirmed by necropsy. Sudden death (days 0-1) was determined by death in the absence of rupture. Heart failure was determined by assessment of body condition score (poor mobility, grooming, hunching, etc) on live animals before euthanasia. Sham surgeries were performed in the same way as infarcts, except that after pericardial tearing the animal was sutured without ligation of the coronary artery. Functional analyses were performed at baseline (before surgery) and 28 days post-surgery. Vevo 2100 ultrasound imaging system (FUJIFILM/VisualSonics Inc., Canada) was used for morphological and functional evaluation of hearts. Animals were anesthetized with isoflurane with controlled body temperature and heart rate for functional imaging. Baseline measurements were obtained using parasternal long (PSLAX) and short (SAX) axis B-mode imaging. Used parameters were endocardial and epicardial length and area in systole and diastole.

### Single Cell Isolation {#sec4.4.2}

The protocol for cell isolation was adapted from [@bib11]. Heart ventricles were dissociated, mechanically cut into small pieces with a scalpel and subjected to two 15min digestions with 263U/ml collagenase type II (Worthington Biochemical Corporation, LS004177), under magnetic stirring at 250rpm, 37°C. The cell suspension was passed through a 40 μm cell strainer to remove cardiomyocytes, small fragment of undigested tissue and collected on ice in a conical 50ml tube containing 2%FCS (VWR Seradigm, 97068-085) in PBS. Cells were spun at 300*g* for 5 min and pre-warmed red cell lysis buffer (Sigma-Aldrich, R7757) was added for 1 min to remove blood cells. After washing, cell pellets were resuspended in 200 μL Dead Cell Removal MicroBeads (Miltenyi Biotec, 130-090-101) and incubated 10 min at room temperature in the dark. The mix of cells and beads was diluted in binding buffer (Miltenyi Biotec, 130-090-101) and an AutoMACS Separator was used to deplete dead cells bound to the magnetic beads.

After centrifugation at 400*g* for 5 min, cells were resuspended in 2%FCS+2mM EDTA and stained with 2μM DRAQ5 (eBioscience, 65-0880-92) followed by 3 μM Propidium Iodine (Sigma-Aldrich, P4864) after 5min. Single live nucleated cells were sorted on a BD AriaII with 130μm nozzle to minimize pressure over cells (12psi). 16-32,000 events were sorted in 0.04%BSA, centrifuged for 8min at 400*g*, resuspended and diluted to 320-400cells/μl for scRNaseq (10x Genomics).

### Single-cell transcriptome barcoding and library preparation for Illumina sequencing {#sec4.4.3}

Single cell capture, barcoding and library preparation were performed with the 10x Chromium system using version 2 chemistry, according to the manufacturer's protocol (10x Genomics, \#CG00052). Approximately 12,000 cells were loaded into one lane of a 10x Chromium microfluidic chip. 1 channel was used per sample (11 total) on 3 chips. Following capture and lysis, cDNA was synthesized and amplified (12 cycles) as per manufacturer's protocol (10x Genomics). The amplified cDNA from each channel was used to construct an Illumina sequencing library. cDNA and libraries were checked for quality on an Agilent 4200 TapeStation, quantified by KAPA qPCR, and sequenced on an Illumina HiSeq 4000 with 150 cycle sequencing to an average depth of 46,000 reads per cell. Detailed information on the cDNA and library yield, sequencing saturation and estimated number of captured cells per sample can be found in [Table S1](#mmc2){ref-type="supplementary-material"}.

### Single-cell RNA-seq data analysis {#sec4.4.4}

#### Processing of sequencing reads {#sec4.4.4.1}

Raw Illumina data were processed using CellRanger v2.1 (10x Genomics) to convert Illumina basecall files to FASTQ format, align sequencing reads to the appropriate genome using the STAR aligner ([@bib15]), and quantify gene expression. For cells isolated from B6J mice, the mouse reference genome (GRCm38/mm10) was used with an extra contig added to allow alignment of reads derived from transgenic ZsGreen sequence. Specifically, the sequence of the plasmid used to generate the transgenic mouse was obtained from <http://www.addgene.org/browse/sequence/162422/>. The 1680bp used sequence included the complete ZsGreen coding sequence, a downstream 589bp WPRE sequence, and the poly(A) signal. For cells isolated from 129 mice, variant calls from the Mouse Genomes Project ([@bib39]) were obtained and g2gtools (<https://github.com/churchill-lab/g2gtools>) was used to replace single nucleotide variants, insertions, and deletions in the reference genome to create a 129-specific reference genome to which reads were aligned. Individual sequencing runs were processed using the "cellranger count" command, and aggregated runs from all time points processed using the "cellranger aggr" command, specifying argument "--normalize=mapped" for depth normalization.

#### Data quality control, normalization, clustering, and marker analysis {#sec4.4.4.2}

The Seurat software package version 2.3.4 ([@bib9], [@bib53]) was used in R version 3.4.1 ([@bib63]) to analyze processed scRNA-Seq data. Data from 38,555 cells that passed CellRanger's quality control steps were obtained. 36,847 cells were retained after filtering out cells in which \< 500 or \> 5,000 genes were detected; \> 10% of reads derived from mitochondria; or \> 15,000 UMIs were sequenced. Expression of 27,999 transcripts was quantified, of which 18,862 were expressed in at least one cell. Read counts were normalized using log transformation. Cell cycle stage was estimated and regressed out using methods implemented in Seurat (and detailed at <https://satijalab.org/seurat/v3.0/cell_cycle_vignette.html>). In addition to cell cycle stage, the number of genes detected, number of UMIs detected, and percentage of mitochondrial reads were also regressed out. Variable genes were detected using the Seurat function FindVariableGenes with default parameters except y.cutoff = 0.5. Dimensionality reduction was used to explore transcriptional heterogeneity and for clustering. Specifically, PCA was used for dimensionality reduction. The first 24 principal components (PCs) were used as input for a graph-based approach to cluster cells by cell type using resolution 0.5 and as input to t-SNE for reduction to two dimensions to facilitate visualization ([@bib83]).

Average expression of all genes per time-point and per cluster were obtained. Two Seurat functions were employed to identify marker genes: FindAllMarkers() to compare each cluster with all the others, and FindMarkers() for pairwise comparisons among clusters/sub-clusters. For each marker gene of clusters, the average fold change (avg_logFC), percentage of expression in each specific cluster (pct.1), percentage of expression in all the other clusters (pct.2), and adjusted *p-value* (p_val_adj) were calculated, as reported in [Tables S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}). Avg-logFC was chosen to represent cluster-specific markers.

#### SPRING visualization {#sec4.4.4.3}

The used SPRING ([@bib85]) viewer web-interface that can be found at <https://kleintools.hms.harvard.edu/tools/spring.html>. For visualization, the following parameters were used: Number of PCA dimensions = 25; Gene filtering - minimum counts = 3; Gene filtering - gene variability percentile = 80.0; Number of nearest neighbors = 5; Cell filtering - minimum counts = 0.0; Gene filtering - minimum cells = 3.0. Data matrixes of clusters of interest retrieved from the Seurat object containing all time-points were uploaded. List of genes, clustering and temporal information derived from meta data associated with the Seurat objects were also provided.

#### Stromal cell sub-clustering {#sec4.4.4.4}

In order to explore transcriptional heterogeneity within stromal cell clusters, the complete matrix of single cell transcriptomes and the data from selected populations (Fibroblasts I, Fibroblasts II, Fibroblasts III, Myofibroblasts and Epicardium; clusters 0,4,6,7,12) were re-normalized and clustered. Specifically, highly variable genes were identified, and the gene expression matrix was reduced in dimensionality using PCA. The first 20 PCs were selected and a graph-based clustering method implemented in Seurat was employed to cluster cells (resolution 0.5).

#### Doublets prediction {#sec4.4.4.5}

Cell doublets were predicted using DoubletFinder version 2.0.2 ([@bib55], <https://github.com/chris-mcginnis-ucsf/DoubletFinder>). DoubletFinder identifies doublets according to each cell's gene expression proximity to artificial doublets created by averaging the transcriptional profile of randomly chosen cell pairs. DoubletFinder was run independently on each single cell library from the 7 time point experiment, to ensure that simulated doublets did not include cells from different libraries which would be impossible to observe. For all libraries, a 6% (true) doublet rate was assumed, 25 principal components were used, and the default value of 25% was used for pN (the number of generated artificial doublets expressed as a proportion of the merged real-artificial data). For each library, the PC neighborhood size pK was estimated using as the maxima of the distribution of mean-variance normalized bimodality coefficient scores, as suggested by the developers.

#### Integration of data from different murine strains {#sec4.4.4.6}

Single cell transcriptomes derived from mice of different genetic backgrounds require careful integration before joint analysis can be performed. In particular, the same cell type may show variability in gene expression in genetically distinct mice due to genetic regulation of gene expression. The Harmony R package version 0.0.0.9000 ([@bib43]) was used to integrate data from B6J and 129 cells. This software takes cells from the strains and projects them onto a shared embedding, allowing for joint clustering and analysis of the combined data. Before running Harmony, data were processed using simple criteria with the Seurat package. First, raw data matrices were read from each 10x Chromium sample. 18,006 genes quantified in both B6J and 129 backgrounds were retained for further analysis. Second, cells were filtered using automated criteria. Cells with a very low or high number of UMIs or number of genes expressed were filtered (minimum 1000 UMI and 500 genes expressed; cells with a UMI \[number of genes\] count greater than three standard deviations from the mean UMI \[number of genes\] count of all cells were discarded). Furthermore, cells with \> 30% mitochondrial reads were discarded. Third, the top 1000 variable genes were identified. Fourth, data were normalized, with signal due to the number of UMI and percent mitochondrial reads regressed out. Fifth, PCA was conducted on the complete dataset including B6J d0 - 6608 cells; B6J sham, n = 2 - 4710 cells; 129 sham - 4213 cells; d3 MI B6J - 3950 cells; d3 MI 129 - 4128 cells. To run Harmony, 80 PCs were used and the RunHarmony() function available at <https://github.com/immunogenomics/harmony> was used to integrate data with parameters: theta = 1; max.iter.harmony = 20. Finally, t-SNE was computed and cells were clustered using the graph-based clustering method implemented in Seurat.

#### Differential gene expression across different strains {#sec4.4.4.7}

The MAST software([@bib20]) was used to enquire differential gene expression between strains in different conditions (sham and d3 post-MI). Tests were carried out using the MASTcpmDetRate method ([@bib73]).This method tests for differences using log- and library size-normalized counts, with cellular detection rate as a covariate, and was among the most powerful and accurate methods for differential expression analysis of single cell RNA-Seq ([@bib73]). Analysis of the differentially expressed genes to identify enrichment of particular biological functions was performed using Ingenuity Pathway Analysis (QIAGEN) and Panther ([@bib57]). The score of each relevant GO-term was calculated as the ratio of the number of query genes associated with the term divided by the total number of genes in the genome associated with the term. Lists of mouse genes associated with each GO term were obtained from the Mouse Genome Informatics database at the link <http://www.informatics.jax.org/downloads/reports/gene_association.mgi.gz> (accessed January 14, 2019).

### Tissue processing for cryosectioning {#sec4.4.5}

Following animal euthanasia, hearts were perfused with 1x HBSS, transferred to 0.5mM KCl for cardiac cycle arrest in diastole, fixed in 4% paraformaldehyde (PFA) for 30min-1 hour at 4°C, permeated with 30% sucrose overnight at 4°C and embedded in Fisher Healthcare Tissue OCT Compound on dry ice. 8 μm cryosections were obtained using the Cryostar NX70 (Thermo Fisher).

### Immunofluorescence {#sec4.4.6}

Cryosections were dried for two hours at room temperature, re-fixed in 2% PFA for 10 min, permeabilized with 0.5% Triton for 15 min, blocked with 5% BSA in 50mM Glycine PBS, and stained with primary antibodies diluted in blocking solution, overnight at 4°C. The following antibodies were used: WT1(1:100, Abcam, ab89901), DKK3 (1:100, R&D Systems, AF948), CTHRC1 (1:100, Thermo Fisher, PA5-49638), ACTA2 (1:100, Sigma Aldrich, A5228, clone 1A4), MT1a (1:100, Enzo Life Sciences, ADI-SPA-550-D), CD45 (1:100, BD Biosciences, 550539, clone 30-F11), CLU (1:100, MyBioSource, MBS9215265, clone RB18701), SFRP2 (1:50, R&D Systems, MAB1169, clone 331022). Used secondary antibodies were Invitrogen Alexa Fluor 568 Donkey anti-Goat (A-11057), Goat anti-Mouse (A-11031), Goat anti-Rabbit (A-11011); Alexa Fluor 647 Goat anti-Rat (A-21247), Goat anti-mouse IgG2a (A-21241), and Goat anti-Rabbit (A-21244) diluted 1:500 or 1:1000 in PBS. Nuclei were stained with DAPI (0.1μg/ml, Thermo Fisher, D1306).

### Imaging {#sec4.4.7}

Bright field and fluorescent whole mount images of full hearts were captured on a stereo-microscope (Leica, MZ10F), equipped with a color/fluorescence camera (Leica, DFC 450c). Scale bars were added and images processed using the LAS software v4.8. Immunofluorescence images were acquired using either an upright fluorescent microscope (Zeiss, Axio Imager.Z2), equipped with X-Cite 120LED excitation source (Excelitas Technologies), using a 20x objective (Zeiss, Plan-Apochromat" 20x/0.8), and the ZEN2 software (Zeiss, blue edition) for acquisition, or using confocal imaging (SP8-AOBS, Leica) with 40x (Leica, HC PL APO 40x/1.30 Oil CS2, FWD = 0.24 mm) or 63x (Leica, HC PL APO 63x/1.40 Oil CS2, FWD = 0.14) objectives, using very-high sensitivity HyD detectors for the emission of 488, 561 and 633 lasers, and the LASX software. At least 3 independent rounds of stainings were done and images were acquired keeping same setting across all time-points used in the comparison analysis. All quantification and image processing were performed using Fiji version 1.0 ([@bib69]). Z stacks with 0.5 μm step size were converted by Z-projection of the average intensity for each channel. Individual channels were merged and pseudo-colored.

### Flow cytometry and cell sorting for bulk RNA isolation {#sec4.4.8}

For qPCR validations, interstitial cells were isolated as described above, from the whole ventricles of control mice or scar area and distal area in injured mice. In experiments with *Coll1a1*^*eGFP*^ mice, GFP^+^DRAQ5^+^PI^-^ cells were sorted on Aria II with 130 μm nozzle. In absence of a fluorescent reporter (129, B6J mice), cells were first resuspended in blocking solution containing anti-mouse CD16/CD32 (1:600, Leinco Technologies, C381, clone 2.4G2) in 2% FCS 5min at RT, then stained with APC/Cyanine7 anti-mouse CD45 (1:660, BioLegend, 103115, clone 30-F11), PE-Cy7 anti-mouse CD31 (1:800, BD Biosciences, 561410, clone 390) on ice for 15min. After washing in PBS, cells were resuspended in 2%FCS+2mM EDTA and DAPI (50ng/ml) before sorting on the AriaII for DAPI^-^CD45^-^CD31^-^cells.

### RNA extraction and quantitative PCR {#sec4.4.9}

RNA was isolated from bulk sorted cells using the RNAqueous-Micro Total RNA Isolation Kit (Thermo Fisher, AM1931), according to manufacturer's instructions. cDNA synthesis was performed using the SuperScript IV VILO Master Mix with ezDNase Enzyme (Thermo Fisher, 11766050). qPCR reactions were performed using Power SYBR Green PCR Master Mix (Thermo Fisher, 4367659) on ViiA 7 Real-Time PCR System with 384-Well Block (Thermo Fisher). 4ng of RNA were loaded per reaction. Primers were designed using IDT primer design tool and BLAST, tested with standard curves on 4 serial 5-fold dilutions. The following primers were used: *Comp* F: 5′-ACATAGATGGCGACCGAATAC-3′, R: 5′-CCTCTGGTCTGGGTTATCTTTC-3′; *Acta2* F: 5′-TCTTTCATTGGGATGGAGTCAG-3′, R: 5′-GACAGGACGTTGTTAGCATAGA-3′; *Cthrc1* 5′-CCCATCGAAGCCATCATCTATC-3′, R: 5′-TCACAGAGTCCTTCCACAGA-3′; *Sfrp2* F: 5′-AGAGGAAGCTCCCAAGGT-3′, R: 5′-GGTGTCTCTGTTGATGTACGTTAT-3′; *Ecrg4* F: 5′-CTGGGTCCAGATGGCATAAG-3′, R: 5′- GTTCTCGGCTACAGCTACATT-3′**;** *Wisp2* F: 5′-TTGAAGCTGGCTCCACAAG-3′; R: 5′-GGGCATACACCATTGAGAGAAT-3′; *Meox1* F: 5′-GGGAGGATTGCATGGTACTT-3′, R: 5′-CTGGTTGTCTGACCTCTCTTT-3′; *Col8a1* F: 5′-GCTCAAGAAGCTGTTCTGTAAATC-3′, R: 5′-CCAGTAGAATCGAGGACCAAAG-3′; *Tnc* F: 5′-CCAGGGTTGCCACCTATTT-3′, R: 5′-GTCTAGAGGATCCCACTCTACTT-3′; *Thbs4* F: 5′-GCTCCTTGGAGAGGTGAAAG-3′, R: 5′-AAAGCTGAGAGGACCACAAG-3′; *Cxcl14* F: 5′-GCTCTTGGTGGTGACGATAA-3′, R: 5′-GCTACAGCGACGTGAAGAA-3′; *Saa3* F: 5′-GCCTTCCATTGCCATCATTC-3′, R: 5′-CACATGTCTCTAGACCCTTGAC-3′; *Serpina3n* F: 5′-TGCAGTCTACAGAGCTGAAACC-3′, R: 5′-CAACCCTGAACATCGGGAGT-3′; *Fn1* F: 5′-TCCTGTCTACCTCACAGACTAC-3′, R: 5′-GTCTACTCCACCGAACAACAA-3′; *F2r* F: 5′-TGGAGGGTAGGGCAGTCTAC-3′, R: 5′-GTGTACACGGAGGGCATGAA-3′; *Serpine1* F: 5′-TCCACAAGTCTGATGGCAGC-3′, R: 5′-TGGTAGGGCAGTTCCACAAC −3′; *Plat* F: 5′-CGAAAGCTGACGTGGGAATA-3′, R: 5′-GTGTGAGGTGATGTCTGTGTAG-3′; *Anxa2* F: 5′-CAAGACCAAAGGAGTGGATGAG-3′, R: 5′-CTGATAGGCGAAGGCAATGT-3′; *Dcn* F: 5′-CTGGCCAATGTTCCTCATCT-3′, R: 5′- AAGGTAGACGACCTGGATATACT-3′;*Col5a1* F: 5′-CACCTTGATCCTCGACTGTAAG-3′, R: 5′-TGTTGGATGTCACCCTCAAATA-3′; *Col4a2* F: 5′-ACAATCACCACCAAAGGGGA-3′, R: 5′-GGAATCCATCCAGCCCATCC-3′; *Fbln5* F: 5′-TGTCTGCGTTTGCTCTATGT-3′, R:5′-GAGTATCATGCGTCTCTGTCTG-3′; *Mfap5* F: 5′-AGTCCTGCTTCACCAGTTTAC-3′, R: 5′-GGCAAAGCTCATCTTTCATAGC-3′; *Thbs1* F: 5′-GCCTCTCCTGTGATGAACTATC −3′, R: 5′-CTCTGTTCTCTTCCGTCACTTT-3′; *Serping1* F: 5′-GCTGAGAACACCAACCATAAGA-3′, R: 5′-CCACTTGGCACTCAAGTAGAC-3′; *Tgfb1* F: 5′-CTGAACCAAGGAGACGGAATAC-3′,R: 5′-GGGCTGATCCCGTTGATTT-3′; *Hprt1* ([@bib24]) F: 5′-GCGAGGGAGAGCGTTGGGCT-3′, R: 5′-CATCATCGCTAATCACGACGCTGGG-3′; *Rpl4* ([@bib67]) F: 5′-GCCGCTGGTGGTTGAAGATAA-3′, R: 5′-CGTCGGTTTCTCATTTTGCCC-3′.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Number of biological replicates and statistical significance are specified in figures and figure legends. For Echocardiography baseline measurements of B6J (n = 14) and 129 (n = 13) strains, an average of 3 measurements of each parameter were obtained per animal (standard deviation \< 0.5). To evaluate the response to MI of different inbred strains the following mice were used: NOD/ShiLtJ, n = 13, NZO/HILtJ, n = 16, 129S1/SvlmJ, n = 34, DBA/2J; n = 9, A/J; n = 14, CAST/EiJ, n = 18; WSB/EiJ, n = 12, PWK/PhJ, n = 11, C57BL/6J n = 13.

For immunostaining quantification, we used 5-6 fields per time-point and calculated mean and standard error of the mean. Unpaired, two-tailed Student's t test was used for pairwise comparison of data between groups. *P value* of less than 0.05 was considered significant. For qPCR analysis we used 3 technical replicates of 3 biological replicates. We calculated *e*ˆ- ΔΔC~t,~ where *e* is the efficiency of each primer pair derived from the standard curve, ΔΔC~t~ is obtained by normalizing C~t~ values on the geometric mean of two housekeeping genes (*Rpl4* and *Hprt1)* over the refence sample. The median, 25th and 75th percentile, maximum and minimum values are represented with box and whisker plots. For statistical analysis, unpaired two-tailed Student's t test, which compares the relative expression values of each gene to the values of the reference sample used for normalization. *P*-value of less than 0.05 was considered significant. Excel v16.16.7 and GraphPad Prism v7.0 were used for the analysis, generation of graphs and statistics. For differential gene expression analysis between 129 and B6J, a threshold of 2-fold expression change and *P*-value $\leq$0.01 were used. False discovery rate (FDR)-corrected *P*-values were used for sorting the results from Panther analysis. *P*-values of overlap and Benjamini-Hochberg (B-H) corrected *P* -values were used for the upstream regulators and canonical pathway analysis respectively (Ingenuity Pathway Analysis, QIAGEN). For the Kaplan-Meier survival plot, statistical significance was calculated using the Gehan-Breslow-Wilcoxon test.

Data and Code Availability {#sec4.6}
--------------------------

### Data resources {#sec4.6.1}

R scripts utilized in the study can be obtained upon request. The accession number for the sequencing data reported in this paper is ArrayExpress: E-MTAB-7895.
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